Pages
DCHS payroll provider is changing!
From 1 April 2022 we're moving from our current payroll provider Shared Business Services (SBS) to a new payroll provider University Hospitals of Derby & Burton NHS FT (UHDB).
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-payroll-provider-changing
Baby loss Awareness Week 9 – 15 October
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/baby-loss-awareness-week-9-15-october
Friday 23 December – latest update on critical incident status
https://dchs.nhs.uk/news/friday-23-december-latest-update-critical-incident-status
Building Belper’s new health centre.. A peek at progress on site!
https://dchs.nhs.uk/news/building-belpers-new-health-centre-peek-progress-site
Files
PAT Procedure
PAT Procedure
SPA DCC Calculator v2.0
SPA DCC Calculator v2.0
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010